Johnson & Johnson (JNJ) vs peers

$267.61

Latest weekly close · Market cap $655.3B

JNJ's P/E is 40.6x, compared with 40.0x at the middle of 5 peers.

Peer group: Pharmaceuticals. Updated Oct 23, 2026.

JNJ and Pharmaceuticals, ranked by P/E
Stock	P/E	Own 5-year percentile
JNJJohnson & Johnson	40.6×	100
MRKMerck & Co.	116.9×	89
LLYLilly (Eli)	43.9×	21
PFEPfizer	40.0×	95
BMYBristol Myers Squibb	13.9×	15
ZTSZoetis	13.5×	9
VTRSViatris	n/a	n/a, not ranked
Peer median	40.0×

How to read this comparison

Up to eight covered companies in the same industry, largest market value first.

P/E divides the share price by earnings per share over the last twelve months. The peer median leaves out JNJ and stocks without a reading.

Each percentile compares a stock with its own weekly readings over the last five years, so 20 means its P/E is above 20% of its own past readings. It needs at least 26 weeks of history. It is not a rank against the other stocks in this table.

Different growth rates, margins and financial risks can explain different multiples. Stocks without positive earnings have no reading.

JNJ versus the peer median

+1%

JNJ: 40.6×
Peer median: 40.0×
Own 5-year median: 22.7×

JNJ P/E history Calculate JNJ's implied price